Aldose reductase regulates TNF-α-induced PGE2 production in human colon cancer cells

Cancer Letters

Volumn 252, Issue 2, 2007, Pages 299-306

  Tammali, Ravinder ^a   Ramana, Kota V ^a   Srivastava, Satish K ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aldose reductase; Colon cancer; Inflammation; NF B; PGE2; PKC; TNF

Indexed keywords

ALDEHYDE REDUCTASE; MESSENGER RNA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RISK; CARCINOGENESIS; CELL STRAIN CACO 2; CHEMOPROPHYLAXIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

ALDEHYDE REDUCTASE; BASE SEQUENCE; CACO-2 CELLS; COLONIC NEOPLASMS; DINOPROSTONE; DNA PRIMERS; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; NF-KAPPA B; PROTEIN KINASE C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249732513     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.01.001     Document Type: Article

References (31)

1. Takahashi T., Takasuka N., Iigo M., Baba M., Nishino H., Tsuda H., and Okuyama T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci. 95 (2004) 448-453
2. DeWitt R.C., and Kudsk K.A. The gut's role in metabolism, mucosal barrier function, and gut immunology. Infect. Dis. Clin. North Am. 13 (1999) 465-481
3. Demoule A., Divangahi M., Yahiaoui L., Danialou G., Gvozdic D., Labbe K., Bao W., and Petrof B.J. Endotoxin triggers NF-{kappa}B-dependent upregulation of multiple pro-inflammatory genes in the diaphragm. Am. J. Respir. Crit. Care Med. 174 (2006) 646-653
4. Panja A., Goldberg S., Eckmann L., Krishen P., and Mayer L. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161 (1998) 3675-3684
5. Weaver S.A., Russo M.P., Wright K.L., Kolios G., Jobin C., Robertson D.A., and Ward S.G. Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in colon epithelial cells. Gastroenterology 120 (2001) 1117-1127
6. Courtois F., Seidman E.G., Delvin E., Asselin C., Bernotti S., Ledoux M., and Levy E. Membrane peroxidation by lipopolysaccharide and iron-ascorbate adversely affects Caco-2 cell function: beneficial role of butyricacid. Am. J. Clin. Nutr. 77 (2003) 744-750
7. Jones S.A., Butler R.N., Sanderson I.R., and Wilson J.W. The effect of specific caspase inhibitors on TNF-alpha and butyrate-induced apoptosis of intestinal epithelial cells. Exp. Cell Res. 292 (2004) 29-39
8. Swamy M.V., Cooma I., Patlolla J.M., Simi B., Reddy B.S., and Rao C.V. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol. Cancer Ther. 3 (2004) 215-221
9. Ramana K.V., Friedrich B., Bhatnagar A., and Srivastava S.K. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J. 17 (2003) 315-317
10. Jobin C., Morteau O., Han D.S., and Balfour Sartor R. Specific NF-kappaB blockade selectively inhibits tumour necrosis factor-alpha-induced COX-2 but not constitutive COX-1gene expression in HT-29 cells. Immunology 95 (1998) 537-543
11. Ramana K.V., Bhatnagar A., Srivastava S., Yadav U.C., Awasthi S., Awasthi Y.C., and Srivastava S.K. Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J. Biol. Chem. 281 (2006) 17652-17660
12. Ramana K.V., Chandra D., Srivastava S., Bhatnagar A., Aggarwal B.B., and Srivastava S.K. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem. 277 (2003) 32063-32070
13. Ramana K.V., Bhatnagar A., and Srivastava S.K. Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett. 570 (2004) 189-194
14. Ramana K.V., Friedrich B., Tammali R., West M.B., Bhatnagar A., and Srivastava S.K. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells. Diabetes 54 (2005) 818-829
15. Chen J., Zhao M., Rao R., Inoue H., and Hao C.M. C/EBP{beta} and its binding element are required for NF{kappa}B-induced COX2 expression following hypertonic stress. J. Biol. Chem. 280 (2005) 16354-16359
16. Gokmen-Polar Y., Murray N.R., Velasco M.A., Gatalica Z., and Fields A.P. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res. 61 (2001) 1375-1381
17. Rao C.V., Simi B., Wynn T.T., Garr K., and Reddy B.S. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats. Cancer Res. 56 (1996) 532-537
18. Ogle C.K., Guo X., Hasselgren P.O., Ogle J.D., and Alexander J.W. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur. J. Surg. 163 (1997) 45-51
19. Witthoft T., Eckmann L., Kim J.M., and Kagnoff M.F. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am. J. Physiol. 275 (1998) G564-G571
20. Gillen C.D., Walmsley R.S., Prior P., Andrews H.A., and Allan R.N. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35 (1994) 1590-1592
21. Suganuma M., Okabe S., Marino M.W., Sakai A., Sueoka E., and Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 59 (1999) 4516-4518
22. Kim D.M., Koo S.Y., Jeon K., Kim M.H., Lee J., Hong C.Y., and Jeong S. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res. 63 (2003) 621-626
23. Farah M., Parhar K., Moussavi M., Eivemark S., and Salh B. 5, 6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 285 (2003) G919-G928
24. Lutz N.W., Tome M.E., and Cozzone P.J. Early changes in glucose and phospholipid metabolism following apoptosis induction by IFN-gamma/TNF-alpha in HT-29 cells. FEBS Lett. 544 (2003) 123-128
25. Han D.S., Li F., Holt L., et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279 (2000) G1011-G1022
26. Liu W., Reinmuth N., Stoeltzing O., Parikh A.A., Tellez C., Williams S., Jung Y.D., Fan F., Takeda A., Akagi M., Bar-Eli M., Gallick G.E., and Ellis L.M. Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res. 63 (2003) 3632-3636
27. Nakao S., Ogata Y., Yamamoto Y., Furuyama S., and Sugiya H. Platelet-derived growth factor-induced arachidonic acid release for enhancement of prostaglandin E(2) synthesis in human gingival fibroblasts pretreated with interleukin-1beta. J. Cell Biochem. 92 (2004) 579-590
28. Tammali R., Ramana K.V., Singhal S.S., Awasthi S., and Srivastava S.K. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin e2 production in human colon cancer cells. Cancer Res. 66 19 (2006) 9705-9713
29. Ramana K.V., Fadl A.A., Tammali R., Reddy A.B., Chopra A.K., and Srivastava S.K. Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. J. Biol. Chem. 281 44 (2006) 33019-33029
30. Kawamura I., Lacey E., Yamamoto N., Sakai F., Takeshita S., Inami M., Nishigaki F., Naoe Y., Tsujimoto S., Manda T., Shimomura K., and Goto T. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice. Anticancer Res. 19 (1999) 4105-4111
31. Kawamura I., Lacey E., Inami M., Nishigaki F., Naoe Y., Tsujimoto S., Manda T., and Goto T. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI. Anticancer Res. 19 (1999) 4091-4097